Allergy Therapeutics
AGY.L
#7049
Rank
NZ$0.70 B
Marketcap
$0.15
Share price
3.20%
Change (1 day)
123.58%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -NZ$88.07 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$69.84 Million. In 2024 the company made an earning of -NZ$88.07 Million, an increase over its 2023 earnings that were of -NZ$93.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-NZ$88.07 Million-5.94%
2023-NZ$93.64 Million243.12%
2022-NZ$27.29 Million-403.33%
2021NZ$8.99 M-49.05%
2020NZ$17.65 M82.31%
2019NZ$9.68 M-159.83%
2018-NZ$16.19 Million255.37%
2017-NZ$4.56 Million-84.22%
2016-NZ$28.88 Million-1678.94%
2015NZ$1.82 M-44.28%
2014NZ$3.28 M129.45%
2013NZ$1.43 M-19.85%
2012NZ$1.78 M-127%
2011-NZ$6.61 Million2044.94%
2010-NZ$0.31 Million-99.08%
2009-NZ$33.48 Million-53.32%
2008-NZ$71.71 Million-21.76%
2007-NZ$91.65 Million351.81%
2006-NZ$20.29 Million230.51%
2005-NZ$6.14 Million-219.33%
2004NZ$5.14 M-58.79%
2003NZ$12.48 M-196.03%
2002-NZ$13 Million